HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: Possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis bullosa

Journal of Investigative Dermatology

Volumn 131, Issue 8, 2011, Pages 1771-1774

  Nagy, Nikoletta ^a   Almaani, Noor ^a   Tanaka, Akio ^a   Lai Cheong, Joey E ^a   Techanukul, Tanasit ^a   Mellerio, Jemima E ^a   McGrath, John A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; COLLAGEN TYPE 7 ALPHA 1; COMPLEMENTARY DNA; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PROTEIN C JUN; PROTEIN FOS; UNCLASSIFIED DRUG;

ALLELE; ANTIBODY LABELING; CELL THERAPY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EXON; FIBROBLAST; GENE EXPRESSION; HUMAN; IN VIVO STUDY; KERATINOCYTE; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; WILD TYPE;

EID: 79960316706     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.85     Document Type: Letter

References (16)

1. Calonge MJ, Seoane J, MassaguéJ (2004) Opposite Smad and chicken ovalbumin upstream promoter transcription factor inputs in the regulation of the collagen VII gene promoter by transforming growth factor-beta. J Biol Chem 279:23759-65 (Pubitemid 38685692)
2. Conget P, Rodriguez F, Kramer S et al. (2010) Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bul-losa. Cytotherapy 12:429-31
3. Fine JD, Eady RA, Bauer EA et al. (2008) The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classi-fication of EB. J Am Acad Dermatol 58: 931-50
4. Fritsch A, Loeckermann S, Kern JS et al. (2008) A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest 118:1669-79 (Pubitemid 351632371)
5. Goishi K, Higashiyama S, Klagsbrun M et al. (1995) Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell 6:967-80
6. Hashimoto K, Higashiyama S, Asada H et al. (1994) Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem 269:20060-6 (Pubitemid 24250928)
7. Iwamoto R, Mekada E (2000) Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev 11: 335-44
8. Kern JS, Loeckermann S, Fritsch A et al. (2009) Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stabi-lity of collagen VII favors long-term skin integrity. Mol Ther 17:1605-15
9. Kivisaari A, Kallajoki M, Ala-aho R et al. (2010) Matrix metalloproteinase (MMP)-7 activates heparin-binding EGF-like growth factor in squamous cell carcinomas complicating recessive dystrophic epidermolysis bullosa. Br J Dermatol163:726-35
10. Nakano H, Gasparro FP, Uitto J (2001) UVA-340 as energy source, mimicking natural sun-light, activates the transcription factor AP-1 in cultured fibroblasts: evidence for involvement of protein kinase-C. Photochem Photobiol 74:274-82
11. Ortiz-Urda S, Lin Q, Green CL et al. (2003) Injection of genetically engineered fibro-blasts corrects regenerated human epidermo-lysis bullosa skin tissue. J Clin Invest 111: 251-5 (Pubitemid 36105924)
12. Stanley JR, Rubinstein N, Klaus-Kovtun V (1985) Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. J Invest Dermatol 85:542-5 (Pubitemid 16204229)
13. Venugopal SS, Yan WF, Frew JW et al. (2010) First double-blind randomized clinical trial of intradermal allogeneic fibroblast therapy for recessive dystrophic epidermolysis bullosa randomized against placebo injections re-sulted in similar wound healing that is independent of collagen VII expression. J Invest Dermatol 130(Suppl 2):S67
14. Wong T, Gammon L, Liu L et al. (2008) Potential of fibroblast cell therapy for recessive dys-trophic epidermolysis bullosa. J Invest Der-matol 128:2179-89
15. Woodley DT, Krueger GG, Jorgensen CM et al. (2003) Normal and gene-corrected dys-trophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J Invest Dermatol 121:1021-8 (Pubitemid 37430968)
16. Yan WF, Murrell DF (2010) Fibroblast-based cell therapy strategy for recessive dystro-phic epidermolysis bullosa. Dermatol Clin 28:367-70